Centrex Announces Stratos Completion of Breadboard Prototype - 500 Beiträge pro Seite
eröffnet am 20.10.03 12:12:01 von
neuester Beitrag 20.10.03 12:48:16 von
neuester Beitrag 20.10.03 12:48:16 von
Beiträge: 6
ID: 787.596
ID: 787.596
Aufrufe heute: 0
Gesamt: 254
Gesamt: 254
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
20.04.24, 12:11 | 167 | |
vor 1 Stunde | 161 | |
05.12.14, 17:15 | 155 | |
heute 00:04 | 123 | |
23.10.15, 12:38 | 116 | |
gestern 09:54 | 103 | |
gestern 21:21 | 92 | |
06.03.17, 11:10 | 75 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.161,01 | +1,36 | 217 | |||
2. | 3. | 0,1885 | -0,26 | 90 | |||
3. | 2. | 1,1800 | -14,49 | 77 | |||
4. | 5. | 9,3500 | +1,14 | 60 | |||
5. | 4. | 168,97 | -0,71 | 50 | |||
6. | Neu! | 0,4400 | +3,53 | 36 | |||
7. | Neu! | 4,7950 | +6,91 | 34 | |||
8. | Neu! | 11,905 | +14,97 | 31 |
paar sek. alt
(BSNS WIRE) Centrex Announces Stratos Completion of Breadboard Prototype Desi
n
Centrex Announces Stratos Completion of Breadboard Prototype Design
Health/Medical Writers / Business Editors
TULSA, Okla.--(BUSINESS WIRE)--CNEX--
Centrex, Inc. (OTCBB:CNEX) today announced that Stratos
Product Development, LLC has notified the Company of the completion of
the breadboard prototype design specifications and electromechanical
detail design for the Centrex single molecule nucleic acid detection
(SMD) system. This milestone is the first major step in the
development of an automated, network capable commercialized version of
a device that will be an adaptable, functional and durable integrated
system for biothreat detection.
Centrex`s SMD technology has been exclusively licensed from Los
Alamos National Laboratories and represents advantages over existing
DNA and RNA detection methods as well as culture-based test methods.
The technology eliminates the need for amplification of the target
DNA, which reduces the possibility of false positive and negative test
results - common concerns identified with other test procedures.
Centrex`s detection system is designed to be adaptable to detect a
variety of bacterial or viral organisms by recognizing the unique DNA
or RNA fingerprint of the organism. The instrument, currently being
developed by Stratos will utilize disposable, multipurpose
microfluidics lab cards that incorporate Centrex`s single molecule
nucleic acid detection (SMD) technology. The disposable lab cards are
being developed by Micronics, Inc., a worldwide leader in the field of
microfluidics, under a separate agreement.
Centrex plans to focus on the commercialization of a first product
that provides a simultaneous multi-channel detection system that is
compact, fully automated and capable of monitoring the presence of
biological agents in air, food and water. Potential additional
applications for the Centrex technology include bioterrorism, Homeland
Security, food and water processing, blood supply screening and
general DNA/RNA testing.
For more information, visit the Centrex website at
www.centrexcorporation.com or contact Ron Wheet at (843) 971-4848. For
additional information on Stratos Product Development, LLC visit
www.stratos.com.
This press release contains certain forward-looking statements. We
undertake no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise. Forward-looking statements in this document should be
evaluated together with the many uncertainties that affect our
business. Those uncertainties are discussed in the Company`s SEC
filings.
(BSNS WIRE) Centrex Announces Stratos Completion of Breadboard Prototype Desi
n
Centrex Announces Stratos Completion of Breadboard Prototype Design
Health/Medical Writers / Business Editors
TULSA, Okla.--(BUSINESS WIRE)--CNEX--
Centrex, Inc. (OTCBB:CNEX) today announced that Stratos
Product Development, LLC has notified the Company of the completion of
the breadboard prototype design specifications and electromechanical
detail design for the Centrex single molecule nucleic acid detection
(SMD) system. This milestone is the first major step in the
development of an automated, network capable commercialized version of
a device that will be an adaptable, functional and durable integrated
system for biothreat detection.
Centrex`s SMD technology has been exclusively licensed from Los
Alamos National Laboratories and represents advantages over existing
DNA and RNA detection methods as well as culture-based test methods.
The technology eliminates the need for amplification of the target
DNA, which reduces the possibility of false positive and negative test
results - common concerns identified with other test procedures.
Centrex`s detection system is designed to be adaptable to detect a
variety of bacterial or viral organisms by recognizing the unique DNA
or RNA fingerprint of the organism. The instrument, currently being
developed by Stratos will utilize disposable, multipurpose
microfluidics lab cards that incorporate Centrex`s single molecule
nucleic acid detection (SMD) technology. The disposable lab cards are
being developed by Micronics, Inc., a worldwide leader in the field of
microfluidics, under a separate agreement.
Centrex plans to focus on the commercialization of a first product
that provides a simultaneous multi-channel detection system that is
compact, fully automated and capable of monitoring the presence of
biological agents in air, food and water. Potential additional
applications for the Centrex technology include bioterrorism, Homeland
Security, food and water processing, blood supply screening and
general DNA/RNA testing.
For more information, visit the Centrex website at
www.centrexcorporation.com or contact Ron Wheet at (843) 971-4848. For
additional information on Stratos Product Development, LLC visit
www.stratos.com.
This press release contains certain forward-looking statements. We
undertake no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise. Forward-looking statements in this document should be
evaluated together with the many uncertainties that affect our
business. Those uncertainties are discussed in the Company`s SEC
filings.
Von welcher Website kommt diese Info ?
Auf der Centrex homepage sind keine neuen Nachrichten !!
Bitte verifizieren
Diese nachricht könnte der Zündfunke sein
Auf der Centrex homepage sind keine neuen Nachrichten !!
Bitte verifizieren
Diese nachricht könnte der Zündfunke sein
chart auch interessant nun, kann locker bis 0,18 $ heute hypen.
Geht gut ab. Schon bei 0,085.
Mal sehen wie USA reagiert. Spannender Tag heute.
Mal sehen wie USA reagiert. Spannender Tag heute.
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
215 | ||
90 | ||
78 | ||
58 | ||
55 | ||
35 | ||
34 | ||
29 | ||
27 | ||
25 |
Wertpapier | Beiträge | |
---|---|---|
21 | ||
19 | ||
19 | ||
19 | ||
18 | ||
17 | ||
17 | ||
16 | ||
15 | ||
14 |